72117Ethiqa XR buprenorphine ExtendedRelease I
State & local contract award Virginia Awarded
- Contract number
- A236_P0353767
- Awardee
- COVETRUS NORTH AMERICA
- Contracting organization
- Virginia Commonwealth University
- Cumulative value
- $422.45
About this award
Virginia Commonwealth University awarded a contract to Covetrus North America on September 8, 2026, for the supply of pharmaceutical products. The contract, identified as A236_P0353767, is valued at $422.45 and involves the delivery of Ethiqa XR buprenorphine extended-release medication to VCU Procurement in Virginia. The contract calls for a single unit purchase of this controlled pharmaceutical substance.
Covetrus North America serves as the prime contractor responsible for fulfilling this pharmaceutical supply requirement for Virginia Commonwealth University. The delivery destination is established as VCU Procurement, with performance taking place in Virginia. As a single-unit acquisition with a cumulative value of $422.45, this contract represents a routine pharmaceutical procurement transaction to support the university's operational or clinical needs. No additional contract performance period details beyond the award date of September 8, 2026, are specified in the available documentation.
Line items
| Item | Total |
|---|---|
| 72117Ethiqa XR buprenorphine ExtendedRelease I | $422.45 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A236_P0353767?
Contract A236_P0353767 was awarded to COVETRUS NORTH AMERICA by Virginia Commonwealth University on September 8, 2026.
How much is contract A236_P0353767 worth?
Its cumulative value is $422.45.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award